News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Advaxis, Inc. Explores New Drug Licensing Opportunities
May 7, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS) has entered into a formal business agreement with the Sage Group to introduce potential partnership candidates and develop new licensing opportunities.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Duchenne muscular dystrophy
Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys
July 22, 2025
·
2 min read
·
Tristan Manalac
Funding
Avalyn Pharma Adds $100M Series D for Inhaled Pulmonary Fibrosis Drugs
July 22, 2025
·
2 min read
·
Dan Samorodnitsky
Layoff Tracker
GSK, Sail, BioNTech Cut Staff for Second Time This Year
July 21, 2025
·
164 min read
·
BioSpace Editorial Staff
Manufacturing
Biogen Commits $2B To Expand US Drug Production Amid Tariff Talk
July 21, 2025
·
2 min read
·
Nick Paul Taylor
